TL117 / Suzhou Junde Biotechnology - LARVOL DELTA

Study of TL117 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (clinicaltrials.gov) - P1/2 | N=108 | Active, not recruiting | Sponsor: Suzhou Junde Biotechnology Co., Ltd | Not yet recruiting ➔ Active, not recruiting | Trial completion date: Jan 2024 ➔ Jun 2025 | Trial primary completion date: Jan 2024 ➔ Nov 2024

Combination therapy • Enrollment closed • Metastases • Trial completion date • Trial primary completion date • Head and Neck Cancer • Oncology • Solid Tumor • Squamous Cell Carcinoma • Squamous Cell Carcinoma of Head and Neck